In accordance, we also found a significant enrichment of the BCSC markers CD44, CD49f, P-cadherin, EpCAM, and ALDH1 in human breast cancer brain metastasis when compared with unmatched primary tumors previously analyzed by our group [34,41,42,51]. This evidence concerns the gene CD44 and breast carcinoma.